Markus Heilig

29.2k total citations · 2 hit papers
395 papers, 22.3k citations indexed

About

Markus Heilig is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Behavioral Neuroscience. According to data from OpenAlex, Markus Heilig has authored 395 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 211 papers in Cellular and Molecular Neuroscience, 122 papers in Molecular Biology and 81 papers in Behavioral Neuroscience. Recurrent topics in Markus Heilig's work include Neurotransmitter Receptor Influence on Behavior (121 papers), Neuropeptides and Animal Physiology (97 papers) and Receptor Mechanisms and Signaling (96 papers). Markus Heilig is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (121 papers), Neuropeptides and Animal Physiology (97 papers) and Receptor Mechanisms and Signaling (96 papers). Markus Heilig collaborates with scholars based in United States, Sweden and Germany. Markus Heilig's co-authors include Annika Thorsell, Wolfgang H. Sommer, George F. Koob, Roberto Rimondini, Melanie L. Schwandt, Mark Egli, Rolf Ekman, Roberto Ciccocioppo, Claes Wahlestedt and Yavin Shaham and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Markus Heilig

381 papers receiving 21.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alcohol use disorders

2019 438 citations Markus Heilig, Jürgen Rehm et al. profile →
Hazardous drinking and alcohol use disorders

2022 93 citations James MacKillop, Roberta Agabio et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Heilig United States	85	12.2k	6.7k	4.7k	3.3k	3.1k	395	22.3k
Rainer Spanagel Germany	74	12.1k 1.0×	5.9k 0.9×	3.2k 0.7×	3.9k 1.2×	2.2k 0.7×	340	19.8k
Jane Stewart Canada	69	13.4k 1.1×	5.5k 0.8×	3.9k 0.8×	5.4k 1.7×	3.8k 1.2×	227	20.0k
Harry W.M. Steinbusch Netherlands	76	9.9k 0.8×	7.3k 1.1×	2.7k 0.6×	3.1k 0.9×	2.9k 0.9×	388	22.8k
Scott J. Russo United States	70	6.9k 0.6×	6.0k 0.9×	6.3k 1.3×	3.0k 0.9×	3.7k 1.2×	195	21.4k
Klaus‐Peter Lesch Germany	101	18.0k 1.5×	10.4k 1.6×	6.5k 1.4×	8.1k 2.5×	6.7k 2.2×	635	42.3k
Jane R. Taylor United States	76	10.8k 0.9×	4.8k 0.7×	2.6k 0.5×	6.6k 2.0×	2.3k 0.7×	236	18.7k
Gian Luigi Gessa Italy	80	14.3k 1.2×	5.7k 0.9×	1.6k 0.3×	3.5k 1.1×	2.2k 0.7×	484	22.9k
Kerry J. Ressler United States	99	9.7k 0.8×	5.8k 0.9×	9.8k 2.1×	8.4k 2.6×	5.5k 1.8×	444	35.0k
Abba J. Kastin United States	83	12.0k 1.0×	9.1k 1.4×	3.1k 0.6×	2.4k 0.7×	2.2k 0.7×	663	31.4k
George R. Breese United States	71	10.8k 0.9×	6.0k 0.9×	2.4k 0.5×	2.5k 0.8×	1.6k 0.5×	338	18.3k

Countries citing papers authored by Markus Heilig

Since Specialization

Citations

This map shows the geographic impact of Markus Heilig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Heilig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Heilig more than expected).

Fields of papers citing papers by Markus Heilig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Heilig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Heilig. The network helps show where Markus Heilig may publish in the future.

Co-authorship network of co-authors of Markus Heilig

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Heilig. A scholar is included among the top collaborators of Markus Heilig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Heilig. Markus Heilig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Östman, Margareta, Daniel Roche, Elisabeth Paul, et al.. (2025). Individual and additive effects of childhood maltreatment and substance use disorder histories on baseline and stress-induced changes in peripheral stress biomarkers. Psychopharmacology. 243(2). 443–456.

Söderpalm, Bo, Helga Lidö, Johan Franck, et al.. (2025). Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial. The Lancet Regional Health - Europe. 54. 101310–101310.

MacKillop, James, Roberta Agabio, Sarah W. Feldstein Ewing, et al.. (2024). Publisher Correction: Hazardous drinking and alcohol use disorders. Nature Reviews Disease Primers. 10(1). 69–69.

Heilig, Markus, et al.. (2023). Endocannabinoid and neuroendocrine contributions to fear learning in humans. Psychoneuroendocrinology. 153. 106152–106152.

Hamilton, J. Paul, Robin Kämpe, Rebecca Boehme, et al.. (2023). A randomized controlled experimental medicine study of ghrelin in value-based decision making. Journal of Clinical Investigation. 133(12). 12 indexed citations

Paul, Elisabeth, Margareta Östman, Markus Heilig, Helen S. Mayberg, & J. Paul Hamilton. (2023). Towards a multilevel model of major depression: genes, immuno-metabolic function, and cortico-striatal signaling. Translational Psychiatry. 13(1). 171–171. 4 indexed citations

Domi, Esi, et al.. (2023). Activation of GABAB receptors in central amygdala attenuates activity of PKCδ + neurons and suppresses punishment-resistant alcohol self-administration in rats. Neuropsychopharmacology. 48(9). 1386–1395. 13 indexed citations

Perini, Irene, Leah M. Mayo, Andrea Johansson Capusan, et al.. (2023). Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulation. Molecular Psychiatry. 28(6). 2563–2571. 14 indexed citations

Bäckryd, Emmanuel, Markus Heilig, & Mikael Hoffmann. (2021). Opioid availability statistics from the International Narcotics Control Board do not reflect the medical use of opioids: comparison with sales data from Scandinavia. Scandinavian Journal of Pain. 21(4). 696–706. 3 indexed citations

10.

Domi, Esi, Francesco Gobbo, Marco Vènniro, et al.. (2021). A neural substrate of compulsive alcohol use. Science Advances. 7(34). 52 indexed citations

11.

Peng, Shiyu, Zhe Shi, Dongsheng Zhou, et al.. (2021). Reduced motor cortex GABABR function following chronic alcohol exposure. Molecular Psychiatry. 26(2). 383–395. 11 indexed citations

12.

Vènniro, Marco, Matthew L. Banks, Markus Heilig, David H. Epstein, & Yavin Shaham. (2020). Improving translation of animal models of addiction and relapse by reverse translation. Nature reviews. Neuroscience. 21(11). 625–643. 126 indexed citations

13.

Augier, Eric, Estelle Barbier, Russell S. Dulman, et al.. (2018). A molecular mechanism for choosing alcohol over an alternative reward. Science. 360(6395). 1321–1326. 167 indexed citations

14.

Bäckryd, Emmanuel, Markus Heilig, & Mikael Hoffmann. (2017). [Opioid prescription changes in Sweden 2000–2015].. PubMed. 114. 13 indexed citations

15.

Badiani, Aldo, Kent Berridge, Markus Heilig, David Nutt, & Terry E. Robinson. (2017). Addiction research and theory: a commentary on the Surgeon General's Report on alcohol, drugs, and health. Addiction Biology. 23(1). 3–5. 8 indexed citations

16.

Bäckryd, Emmanuel, Markus Heilig, & Mikael Hoffmann. (2017). Dynamiken i förskrivningen av opioider i Sverige 2000–2015 - Markanta omfördelningar inom opioidgruppen, men ingen »epidemi«. Läkartidningen. 114. 3 indexed citations

17.

Zhou, Zhifeng, Camilla Karlsson, Tiebing Liang, et al.. (2013). Loss of metabotropic glutamate receptor 2 escalates alcohol consumption. Proceedings of the National Academy of Sciences. 110(42). 16963–16968. 84 indexed citations

18.

Jerlhag, Elisabet, Emil Egecioglu, Sara Landgren, et al.. (2009). Requirement of central ghrelin signaling for alcohol reward. Proceedings of the National Academy of Sciences. 106(27). 11318–11323. 349 indexed citations

19.

George, David T., Jodi M. Gilman, Jacqueline Hersh, et al.. (2008). Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism. Science. 319(5869). 1536–1539. 168 indexed citations

20.

Pandey, Subhash C., Lucinda G. Carr, Markus Heilig, Erkki Ilveskoski, & Todd E. Thiele. (2003). Neuropeptide Y and Alcoholism: Genetic, Molecular, and Pharmacological Evidence. Alcoholism Clinical and Experimental Research. 27(2). 149–154. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact